MedTrace Logo

Pulmonary Embolism Registry

NCT05391646 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-10-19

No results posted yet for this study

Summary

Acute Pulmonary Embolism (PE) is the most serious clinical presentation of venous thromboembolism (VTE), a leading cause of cardiovascular mortality, exceeded only by stroke and myocardial infarction. Chronic thromboembolic pulmonary hypertension (CTEPH) is the most severe chronic form of CTED and it occurs in 2-4% of patients after acute PE.

In Portugal little is known about PE epidemiology and its outcomes, including complications like CTED. The main goal of this study is, therefore, to understand PE epidemiology and complications in the northern region of Portugal. This information can enable the organization of a structured health care network that can potentially benefit all PE patients.

Conditions

Sponsors & Collaborators

  • Unidade Local de Saúde de Matosinhos, EPE

    collaborator OTHER

  • Centro Hospitalar Universitário do Porto

    collaborator UNKNOWN

  • Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.

    collaborator OTHER_GOV

  • Hospital da Luz, Portugal

    collaborator OTHER

  • Hospital Centre Hospitalar de Trás-os-Montes e Alto Douro

    collaborator OTHER

  • Hospital de Braga

    collaborator OTHER

  • Centro Hospitalar de Entre o Douro e Vouga

    collaborator OTHER

  • Unidade Local de Saúde do Alto Minho

    collaborator OTHER

  • Universidade do Porto

    lead OTHER

Principal Investigators

  • Carolina Guedes, MD, PhDc · Universidade do Porto

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-31
Primary Completion
2023-12-16
Completion
2026-06-16

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05391646 on ClinicalTrials.gov